Wat is de prijs voor MetaStat Inc (MTST)

Het prijs van MetaStat Inc (MTST) is $0.001

Wat is de marktkapitalisatie voor MetaStat Inc (MTST)

Marktkapitalisatie voorMetaStat Inc (MTST) is $5.88K

MetaStat Inc (MTST) Dividendrendement

MetaStat, Inc., a precision medicine company, focuses on discovering and developing therapeutic and diagnostic treatment solutions for cancer patients. The company is developing novel drug candidates and companion diagnostic tests that target the MENA pathway. Its product candidates include MENA diagnostic assay, a tissue-based quantitative immunofluorescence test that measures expression of the pro-metastatic MENA protein splice-variant; companion diagnostic to predict RTK inhibitor drug responses and anti-microtubule drug responses; liquid blood-based biopsy to enhance cancer diagnosis and optimize patient care; MetaSite Breast assay, an immunohistochemistry test that measures micro-anatomical intravasat at blood vessels within the tumor microenvironment ion sites; and prognostic diagnostic to predict risk of cancer metastasis. The company’s therapeutic targets a critical metastatic pathway in solid tumors responsible for driving tumor resistance and the spread of aggressive cancer. MetaStat, Inc. is based in Boston, Massachusetts.

Jaar	Dividendrendement	Wijzigen
Niet genoeg gegevens voor de verstrekte datums.

Jaar

Dividendrendement

Wijzigen

Niet genoeg gegevens voor de verstrekte datums.

Bedrijf	Dividendrendement	Land
Contemporary Amperex Technology Co., Limited 300750.SZ	0.00%	CN
ABB Ltd ABBN.SW	0.00%	CH
Eaton Corporation plc ETN.US	1.03%	IE
Vertiv Holdings Co VRT.US	0.09%	US
Delta Electronics (Thailand) Public Company Limited DELTA.BK	0.00%	TH

Bedrijf

Dividendrendement

Land